Related Experiment Videos

[127 cases of pulmonary fungal infection]

X Qian1, Y Zhu, W Xu

  • 1Department of Respiratory Disease, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.

Abstract

Insights

Pulmonary fungal infections (PFI) often occur in patients with underlying diseases like COPD or leukemia. Early recognition is crucial as PFI has non-specific symptoms and high mortality, especially in those with chronic renal or hematological conditions.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Mycology

Background:

  • Pulmonary fungal infection (PFI) is a significant secondary infection in various underlying diseases.
  • Predisposing conditions, including chronic obstructive pulmonary disease (COPD), systemic lupus erythematosus (SLE), leukemia, and chronic renal disease, are prevalent in PFI cases.

Purpose of the Study:

  • To elucidate the clinical characteristics of pulmonary fungal infections.
  • To evaluate the therapeutic outcomes and prognosis of PFI.
  • To identify major predisposing diseases associated with PFI.

Main Methods:

  • Retrospective analysis of 127 cases diagnosed with pulmonary fungal infection.

Main Results:

  • 95% of patients had predisposing diseases, with COPD, SLE, leukemia, and chronic renal disease being most common.
  • Clinical manifestations were non-specific; bronchitis-type findings on radiography were observed in 61% of cases.
  • Monilia (Candida) was the predominant pathogen (79.5%). High mortality was noted, with chronic renal and hematological diseases identified as risk factors (RR 5.14).

Conclusions:

  • Pulmonary fungal infection is a critical secondary infection, with increasing morbidity.
  • Non-specific clinical features necessitate heightened clinical awareness.
  • Prompt diagnosis and management are essential, particularly in immunocompromised or chronically ill patients.

Related Concept Videos